Search
Filters
Clear All
  • 24

Phase

  • 1
  • 3
  • 1
  • 2
  • 1
  • 14
  • 14
  • 14
  • 24

Found 24 aging trials

A listing of aging medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Sort by:

Investigating Treatment for Children with Heart Failure and Left Ventricular Systolic Dysfunction

R
R. Mark Payne, MD
6 months - 17 years
All genders
Phase 3
Interventional
This study investigates the effects of an investigational medication on children with heart failure and left ventricular systolic dysfunction (LVSD). Heart failure is when the heart cannot pump enough blood, leading to symptoms like shortness of breath and tiredness. LVSD is a specific type of heart failure where the left …
Learn More

Study of Investigational Medication for Type 2 Diabetes in Youth

T
Tamara Hannon, MD
10 years - 17 years
All genders
Phase 3
Interventional
This study investigates the safety and effects of an investigational medication in children and teenagers aged 10 to less than 18 years who have Type 2 Diabetes Mellitus (T2DM). Type 2 diabetes is a condition where the body does not use insulin properly, leading to high blood sugar levels. The …
Learn More

A Randomized Phase II Study Comparing Cytarabine + Daunorubicin(7+3) vs (Daunorubicin and Cytarabine) Liposome, Cytarabine + Daunorubicin +Venetoclax, Azacitidine + Venetoclax, and (Daunorubicin and Cytarabine) Liposome+ Venetoclax in Patients Aged 59 or Younger Who are Considered High-Risk(Adverse) Acute Myeloid Leukemia as Determined by MYELOMATCH; AMyeloMATCH Clinical Trial

R
Rita Assi
18 years - 59 years
All genders
Phase 2
What is the purpose of this study?This phase II MyeloMATCH treatment trial tests whether the standard approach of cytarabine and daunorubicin in comparison to the following experimental regimens works to shrink cancer in patients with high risk acute myeloid leukemia (AML): 1) daunorubicin and cytarabine liposome alone; 2) cytarabine and …
Learn More

Study on Investigational Medication for Recent Onset Type 1 Diabetes

L
Linda DiMeglio, MD
12 years - 35 years
All genders
Phase 1/2
Interventional
This study investigates the safety, tolerability, and effects of an investigational medication for people aged 12 to 35 with recent onset Stage 3 Type 1 diabetes. Type 1 diabetes is a chronic disease where the body's defense system mistakenly attacks specific cells within the pancreas, which make insulin. Insulin helps …
Learn More
21 - 24 of 24